- Audits conducted by Blood Matters that benchmark results can be used to improve policies and procedures, to help health services provide best practice in blood management and transfusion practice.
- The audits can help health services meet the requirements of the Australian Quality and Safety in Healthcare Standards, the Blood Management Standard (7).
Blood Matters audits
The 2023 Blood Matters audit is the appropriate use of fresh frozen plasma (FFP), in accordance with the National Blood Authority Patient Blood Management Guidelines and Australian Red Cross Lifeblood (Lifeblood) - .
The audit has been developed in conjunction with Lifeblood, the National Blood Transfusion Committee and Blood Matters, to gain an understanding of FFP use in adult patients across health services and assess if use is in accordance with current guidelines.
- The audit will be open from 1 April to 30 June 2023.
- Audit instructions and definitions:
- FFP data collection tool:
The audit determines if blood transfusion consent policy and practice has changed. The results will be compared to those of a similar audit conducted in 2012.
It consists of two parts:
- Part A is a blood transfusion consent policy review
- Part B is an audit of blood transfusion consent practice (a retrospective medical record audit of up to 30 patients who have received a blood component transfusion).
The audit will be open from 27 June to 12 August 2022.
The documents below can assist with data collection and submission:
Audit instructions and definitions
Consent audit questions
Part B data collection tool
For best data entry experience, it is recommended to use Chrome. If you only have Microsoft Edge or Explorer, ensure you have the web browser screen maximised to full screen.
The survey will be open from 2 August - 24 September 2021
Limited information is available about the implementation and use of electronic medical records (EMR) with regard to blood management and transfusion practice. This survey will help develop an understanding of current design and implementation of EMRs specific to blood management and transfusion practice.
The survey is designed to identify, the number of health services with an electronic medical record (EMR) and the level of staff participation in the design, development and implementation of the EMR, as well as the clinical quality and safety achieved by using an EMR.
The survey is designed to be completed by different staff in varying roles within the health service. The staff member may or may not have been directly involved in the design and implementation.
This audit has been designed to assess the compliance of practice to the PBM guidelines: Module 2 related to the assessment and management of reversible anaemia prior to elective surgery, and blood conservation strategies used intraoperatively to reduce postoperative anaemia.
To assist with data collection and submission, please see attached documents:
For best data entry experience, it is recommended to use Chrome. If you only have Explorer, ensure you have the web browser in Maximise (full screen) rather than “restored down”.
This survey has been designed to determine what processes are in place within health services to assess anaemia in the perioperative patient undergoing elective procedures in which substantial blood loss is anticipated.
The survey requires an upload of your preoperative assessment template, if applicable. It is suggested you have the file ready in a PDF, doc or docx format before commencing data entry.
For every 100 mL of blood withdrawn for sampling, there is a decrease of 7 g/L in haemoglobin. A reduction in iatrogenic blood loss reduces the risk of anaemia and potentially the need for blood transfusion (NBA 2018). The use of micro-sampling has been shown to significantly reduce the volume of blood loss and has been associated with a significant reduction in blood transfusion (Tinmouth 2008). Implementing strategies to reduce iatrogenic blood loss in an organisation requires strategic planning, communication and implementation with relevant stakeholders such as medical staff, laboratory scientist and nursing staff.
In 2017, Blood Matters undertook a snapshot audit of health service policies and practises that could minimise iatrogenic anaemia associated with blood sampling. This audit builds on the 2017 audit to identify changes in policy and practice, and to assess total blood volume taken from patients for samples (testing & discard).
This audit comprises of two parts:
Part A: Desktop audit of policy and procedures - Audit questions
Part B: Bedside prospective audit of practice – of all patients in one selected clinical area for one week (7 days)
Bedside data collection tool
Excel data entry
Further instructions for this audit can be downloaded here.
The administration of prophylactic RhD Ig to pregnant RhD negative women results in a significant reduction in the incidence of Rh isoimmunisation, leading to a reduction in the risk of haemolytic disease of the newborn, a potentially fatal consequence.
Since January 2015, RhD Ig administration errors have been reportable to Blood Matters serious transfusion incident reporting system (STIR). Common error themes include:
- omission of prophylactic RhD Ig doses; increasing risk for future pregnancies
- administration of RhD Ig inappropriately; exposing women to an unnecessary blood product.
This audit aims to review the policies, procedures, and practices to assess compliance with the current "Guidelines for the use of RhD immunoglobulin in obstetrics in Australia".
The supply of group O RhD negative red blood cells (RBC) units to Australian health services is an ongoing challenge.
Approximately 9 per cent of the Australian population is group O RhD negative, while the demand for O RhD negative units by health services is 15 per cent of total RBC issues. This is expected to a certain degree, due to it being a 'universal' blood group given justifiably to some non-Group O RhD negative recipients, for example in emergencies before the patient's blood group is known. However, it must be acknowledged that group O RhD negative blood is a limited resource and must be used wisely.
The Australian Red Cross Lifeblood Guidelines for the Use of Group O RhD negative red blood cells provide recommendations for the use of Group O RhD negative red blood cells in order to conserve stocks and ensure availability for those patients for whom there is no alternative.
The aim of this audit is to determine how Blood Matters can support health services to meet these guidelines, by better understanding the current pattern of use for group O RhD negative blood, and determining potential recommendations to conserve for O RhD negative inventory.
Currently in Victoria there are no data on practices that are in place to reduce iatrogenic blood loss potentially resulting in anaemia (that is, the anaemia that results from blood loss due to repeated blood sampling to obtain specimens for laboratory testing, also known as hospital-acquired anaemia).
The aim of this audit was to determine how Blood Matters can support health services to reduce this type of blood loss by better understanding what practices are currently in place and what barriers are in place, if any.
Reviewed 21 September 2023